During the opening segment of this program, part of the Healthcare Reform Stakeholders Summit, Spring 2015 series, moderator Dennis Patrick Scanlon, PhD, asks managed care stakeholders for their insights on the goals of healthcare professionals in value-based purchasing programs and the roles of various stakeholders in these programs.
Ateev Mehrotra, MD, MPH, notes that the transition in our healthcare system from volume-based to value-based will force providers to focus on quality, to achieve improved health at reduced costs.
Two categories of payers actively influence value-based purchasing, comments Francois de Brantes, MS, MBA: employers and consumers, whom he refers to as “the new generation of purchasers.” According to Mr de Brantes, a combination of both employers and consumers as payers is driving the change in payment for healthcare.
Arthur Vercillo, MD, FACS, agrees that consumers are the driving force for value-based purchasing programs, adding that the intent of the Affordable Care Act (ACA) was to provide increased access to healthcare. Dr Vercillo, commenting on value in terms of cost and quality, says he doubts if consumers have always gotten their money’s worth, and that value-based purchasing programs are a step in the right direction.
Medicare is the driving force that everyone else follows, according to Dr Mehrotra. While private payers are innovating and seeking alternate models, he strongly believes that Medicare took the lead in terms of initiating value-based purchasing programs, followed by the introduction of similar programs by private payers.
As the discussion continues, Mr de Brantes explains that employers have been a pioneer in this movement since the 2000s, while private sector payers are operationalizing various models more broadly. Acknowledging that private sector payers have gained from the groundwork laid by the ACA and the Center for Medicare & Medicaid Innovation, Mr de Brantes proposes that consideration should be given to what the private sector could and should be doing to drive these efforts forward.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More